SCHEMBL21922613

SCHEMBL21922613

N#Cc1ccc(-c2ccc(-c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc3-4)c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 12/20 0.43
▸ ABCB1 P08183 6/20 0.42
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CLK4 Q9HAZ1 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ PDK2 Q15119 1/20 0.39
▸ ABCC1 P33527 2/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21922814 0.94 ABCG2 (0.44) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21922599 0.93 ABCG2 (0.46) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21396081 0.91 PDK2 (0.47) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21922612 0.91 PDK2 (0.47) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21922493 0.90 ABCG2 (0.43) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21396080 0.90 PDK2 (0.48) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21922609 0.90 CYP1A2 (0.41) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21922603 0.89 PDK2 (0.45) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL22908229 0.89 ABCG2 (0.42) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL21922503 0.89 ABCG2 (0.42) ABCG2ABCB1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542237-B2 Fluorene derivative and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-01-03 — — US disclosed
US-20200131138-A1 FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542237-B2 Fluorene derivative and organic light emitting device comprising same CRY1, CRY2, LEF1 ABCG2 3152/4885ABCB1 1152/4885MEN1 356/4885
US-20200131138-A1 FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, LEF1 ABCG2 3152/4885ABCB1 1152/4885MEN1 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback